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Microglia, the brain's resident macrophages, actively contribute to the homeostasis of
cerebral parenchyma by sensing neuronal activity and supporting synaptic remodeling
and plasticity. While several studies demonstrated different roles for astrocytes in
sleep, the contribution of microglia in the regulation of sleep/wake cycle and in the
modulation of synaptic activity in the different day phases has not been deeply inves-
tigated. Using light as a zeitgeber cue, we studied the effects of microglial depletion
with the colony stimulating factor-1 receptor antagonist PLX5622 on the sleep/wake
cycle and on hippocampal synaptic transmission in male mice. Our data demonstrate
that almost complete microglial depletion increases the duration of NREM sleep and
reduces the hippocampal excitatory neurotransmission. The fractalkine receptor
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CX3CR1 plays a relevant role in these effects, because cx3cr1GFP/GFP mice recapitu-
late what found in PLX5622-treated mice. Furthermore, during the light phase,
microglia express lower levels of cx3cr1 and a reduction of cx3cr1 expression is also
observed when cultured microglial cells are stimulated by ATP, a purinergic molecule
released during sleep. Our findings suggest that microglia participate in the regulation
of sleep, adapting their cx3cr1 expression in response to the light/dark phase, and
modulating synaptic activity in a phase-dependent manner.
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1 | INTRODUCTION
The environmental light changes caused by the 24-h period of
Earth's rotation around its axis modulate the internal clock in our
brain, triggering cycles of alertness and sleepiness in the circadian
rhythm. The role of glial cells in the modulation of the biological cir-
cadian clock is a matter of intense research (Ingiosi et al., 2013;
Garofalo et al., 2020). Several studies point to astrocytes as major
determinants of the glial contribution to synaptic homeostasis dur-
ing the sleep/wake cycle, through the IP3/Ca
2+ signaling pathway
(Foley et al., 2017), modulating the extracellular levels of ATP and
adenosine (Halassa et al., 2009; Nadjar et al., 2013; Porkka-
Heiskanen et al., 1997) and participating to the glymphatic system
for the clearance of metabolites and chemicals from the extracellu-
lar space of the brain (Xie et al., 2013). However, key roles have
been hypothesized also for microglia during normal sleep and upon
sleep disturbances (Bellesi et al., 2017; Choudhury et al., 2020) as
well as in neural plasticity processes associated with synaptic remo-
deling during sleep (Yang et al., 2014; Niethard et al., 2017; de Vivo
et al., 2017; Tuan and Lee, 2019; Stanhope et al., 2020; Zhou
et al., 2020). In particular, microglial cells undergo molecular alter-
ations along the sleep and wake phases, expressing different pat-
terns of cytokines upon inflammatory challenge (Fonken
et al., 2015). Microglia are modulated by the arousal state (Stowell
et al., 2019; Liu et al., 2019) and by sleep deprivation, with effects
on their expression of receptors for neurotransmitters, hormones
and cytokines involved in regulating process motility and phago-
cytic activity (Wisor et al., 2011). Most studies performed to inves-
tigate the effect of sleep and wake on synapses and glial cells used
models of sleep deprivation where the wake phase differs for the
level and quality of stimuli used to avoid sleep (Havekes and
Aton, 2020). To limit possible confounding interference induced by
animal manipulation, we used light as a zeitgeber cue, exposing mice
to 12:12 light/dark cycles (light: Zeitgeber Time [ZT] 0-ZT12, dark:
ZT12-ZT0). We investigated the role of microglial cells by depletion
studies, taking advantage of the role exerted by colony stimulating
factor-1 receptor (CSF-1R) signaling on myeloid lineage cells
(Ginhoux et al., 2010) and of previous reports demonstrating that
CSF-1R deletion or inhibition leads to a near complete elimination
of microglial cells (Erblich et al., 2011, Elmore et al., 2014). We
treated mice with PLX5622, a CSF-1R inhibitor that drastically
reduces the density of microglial cells in different brain regions, and
we analyzed different endpoints: (1) the time spent in sleep or
active states during the light and dark phases of the day; (2) the
basal excitatory synaptic transmission; and (3) neuronal plasticity
processes in the hippocampal region at ZT4 (light) and ZT16 (dark).
These two time points were selected for being far from the light
changes and thus better representing constant behavioral condi-
tions. We described that, in the nearly complete absence of
microglia, mice spent more time sleeping during the dark phase. The
depletion of microglia also affected excitatory synaptic transmission
in a phase-dependent way: (1) abolishing the differences in sponta-
neous excitatory postsynaptic currents (sEPSC) and miniature EPSC
(mEPSC) amplitude and sEPSC frequency between the dark and
light phases and (2) increasing hippocampal long-term potentiation
(LTP) exclusively during the light phase.
The chemokine fractalkine (CX3CL1) receptor (CX3CR1) is
highly expressed in microglia and its genetic deletion in mice dis-
closed multiple regulatory roles of CX3CR1 on brain development,
synapsis maturation, and neuronal function (Paolicelli et al., 2011;
Bolos et al., 2017), as well as on neuronal survival in models on neu-
ropathology (Limatola and Ransohoff, 2014). To investigate whether
the effects induced by microglial depletion were at least in part
dependent on microglial CX3CR1 signaling, the sleep/wake cycle
and the excitatory synaptic transmission along the light/dark cycle
were also investigated in cx3cr1GFP/GFP mice, where CX3CR1 is
deleted (Jung et al., 2000), with outcomes comparable to microglia-
depleted mice. Furthermore, we report that microglial cx3cr1 expres-
sion is lower during the light phase and that, in vitro, it is modulated
by the sleep-dependent metabolite ATP, thus suggesting that
CX3CR1 plays a central role in regulating microglial responses during
the light/dark cycle.
In conclusion, we demonstrated that under physiological condi-
tions, microglia affect the duration of sleep and are necessary for syn-
aptic changes occurring during the wake phase, disclosing also a key
role for CX3CR1 in sleep–wake cycle.
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2 | MATERIALS AND METHODS
2.1 | Animals
Experiments described in the present work were approved by the Ital-
ian Ministry of Health in accordance with the guidelines on the ethical
use of animals from the European Community Council Directive of
September 22, 2010 (2010/63/EU), the Italian D. Leg. 26/2014. All
possible efforts were made to minimize animal suffering and to reduce
the number of animals used per condition by calculating the necessary
sample size before performing the experiments.
To avoid sex- and gonadal hormone-related variations, we
decided to always use male mice. Eight- to 10-week-old
C57BL/6N mice were obtained from European Mouse Mutant
Archive (EMMA, Monterotondo, Italy); homozygous cx3cr1GFP/GFP
mice Cat# JAX:005582, RRID: IMSR_JAX:005582 (https://www.
jax.org/strain/005582) and C57BL6/J mice Cat# JAX:000664,
RRID: IMSR_JAX:000664 (https://www.jax.org/strain/000664)
were obtained from The Jackson Laboratory (Bar Harbor, ME,
USA). C57BL6/J mice were used as controls for cx3cr1GFP/GFP
mice, given the similarity in the genetic background, as suggested
by The Jackson Laboratory. For real-time PCR analyses and elec-
trophysiological recordings, mice were rapidly anesthetized inside
the home cage.
2.2 | Housing and light conditions
Mice were housed in standard breeding cages at a constant tempera-
ture (22 ± 1C) and relative humidity (50%). Food and water were
available ad libitum.
Before any experimental intervention, all mice were housed for at
least 7 days upon arrival with a 12:12 h light/dark cycle (light 7:00,
ZT0; dark 19:00, ZT12). The same light conditions were kept for all
experimental phases, except for the electrophysiology experiments
performed in hippocampal slices during the dark phase (see below).
2.3 | PLX5622 treatment
Microglial depletion was achieved by administering the Plexxikon
CSF1R inhibitor PLX5622 (1200 PPM added to AIN-76A chow,
Research Diets) to C57BL/6N mice at least 7 days before experiments
and its administration continued until the end of the experiments.
Age-matched control group received control diet (AIN-76A, Research
Diets).
2.4 | Video-electroencephalography and
electromyography recordings
We performed 24 h electroencephalography (EEG) recordings in mice
treated for 2 weeks with PLX5622 (n = 9), in cx3cr1GFP/GFP mice
(n = 7) and in age-matched control mice (C57BL/6N, n = 10; C57BL/
6J, n = 4). Experimental procedures were validated in European pro-
ject “PharmaCog” and reported in detail elsewhere (Del Percio
et al., 2017). Before surgery, mice were acclimatized to the recording
cages for 7 days (2–5 min per day). Stainless steel insulated epidural
EEG exploring electrodes (Bilaney Consultants GmbH, Cat# E363/20/
SPC) were implanted under isoflurane (3%) anesthesia and intraperito-
neal injection of Rompun (20 mg/ml) at 75 mg/kg + Zoletil (50 mg/
ml) at 20 mg/kg over the anterior frontal (from Paxinos atlas Bregma:
AP +2.8 mm and ML at 0.5 mm) and posterior parietal (AP 2.0 mm
and ML 2.0 mm) cortical regions. They were referred to an electrode
placed in the cerebellum (nose bone ground). Another electrode
(15 mm shaft, Bilaney Consultants GmbH, Cat# E363-3-SPC) was
positioned into the dorsal back muscles to record electromyographic
(EMG) activity useful to monitor the motor activity. A few hours after
the surgery, mice were treated by systemic analgesics and antibiotics.
PLX5622 and control chow administration started at this moment and
continued until the end of the experiment. After 1 week of full recov-
ery following the electrodes implantation, mice experienced 1 week
of handling and plugging–unplugging operations every day (2–5 min
per day). The day before the experiment, the mice were placed in the
recording cage for acclimatization.
Grass Technologies ©2011 (Twin software 4.5.3.23) was used for
simultaneous EEG, EMG, and video recordings performed on pairs of
mice for 24 h (12 h lights and 12 h dark). Each pair was formed by one
PLX5622 or cx3cr1GFP/GFP and one control mouse. The mice were
simultaneously connected to a system consisting of AS40 Amplifier by
a flexible cable. The EEG and EMG data were collected with a sam-
pling rate of 200 Hz and an antialiasing band pass analogue filter.
The video-EEG–EMG analysis was initially performed in five con-
trols and five PLX5622-treated mice for the whole dark and light
period, only excluding the first hour after light change (22 h in total).
The results of this exploratory analysis are reported in the supplemen-
tary results (Figure S2) and revealed that comparable information can
be obtained by analyzing shorter periods (7 h each phase). In consider-
ation of the time-consuming procedure of analysis, the EEG–EMG
analysis was limited from ZT4 to ZT11 in the light period and from
ZT13 to ZT20 in the dark period.
Each video and EEG–EMG recording epoch lasting 8 s has been
classified into the following behavioral classes:
1. Active behavior (movement condition). The mice performed overt
movements in the cage for most of the given epoch of 8 s. The
movements were characterized by ample displacements of body
parts such as trunk, head, and forelimbs. Significant EMG activity
was expected in this behavioral condition.
2. Passive behavior (passive wake condition). The mice showed no
movement (i.e., substantial immobility) periods intermingled with
small movements of the trunk, head, and forelimbs for the majority
of 8 s. The maximal duration of immobility considering two
contiguous epochs was 8 s. This criterion was expected to mini-
mize the risk that “passive condition” could be misclassified as
sleep and vice–versa.
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3. Immobility condition. The mice performed no movement of the
trunk, head, and forelimbs for at least 20 s across three or more
epochs. This condition was associated with a low EMG activity and
required the analysis of the ongoing EEG and EMG waves for a dis-
crimination between a condition of passive behavior and sleep (see
below).
4. Undefined. Each epoch classified as undefined showed a mix of
behavioral classes or lack of clarity about the behavioral situation
of the mice. The number of undefined epochs in all groups of mice
was less that 1 out of 1000 epochs, and there were no statistical
differences in the undefined epochs among the groups (Mann
Whitney U test, p > .05 uncorrected). Since the undefined epochs
were negligible, they were not considered in the calculation of the
percentage of time spent in sleep and wake. Consequently, the
summed percentage of time spent in sleep and wake was equal to
100% in the reported results due to that approximation.
Afterward, the periods classified as “Immobility” were evaluated
based on a standard visual analysis of EEG and EMG data. The classifi-
cation of the animal immobility as non-rapid eye movement (NREM)
sleep was based on the observation of sleep spindles (quite infre-
quent) and EEG slow sleep waves, whereas the classification as rapid
eye movement (REM) sleep was based on the behavioral sleep state
associated with low EMG activity and the following EEG features:
dominant theta waves and no sleep spindles and EEG slow waves (Del
Percio et al., 2017).
2.5 | Slice preparation for electrophysiology
For electrophysiology, mice were sacrificed during the light phase at
ZT4 and during the dark phase at ZT16. In order to perform all the
electrophysiological recordings during the working time of the day,
mice sacrificed at ZT16 received a light/dark cycle inversion (light
on at 19:00) for at least 14 days prior to start the control chow or
PLX5622 treatment, for microglia depletion in wild-type mice. In
this way, slices were harvested at 11:00 for all groups. To verify that
light/dark cycle inversion did not affect the results of the experi-
ments, a group of control mice receiving the normal light/dark cycle
was sacrificed at 23:00. No significant differences were observed
between the ZT16 groups in normal and inverted cycles and data
were pooled.
For slicing preparation, anesthetized animals were decapitated
and the whole brains were rapidly removed from the skull and
immersed for 10 min in ice-cold artificial cerebrospinal fluid (ACSF;
composition in mM: NaCl 125, KCl 4, CaCl2 2.5, MgSO4 1.5, NaH2PO4
1, NaHCO3 26, and glucose 10; 295–300 mOsm), continuously oxy-
genated with 95% O2 and 5% CO2 to maintain the proper pH (7.4).
Transverse 350 μm slices were cut at 4C with a vibratome (Thermo
Scientific, USA) and then placed in a chamber containing oxygenated
ACSF. After their preparation, slices were allowed to recover for at
least 1 h at 30C.
2.6 | Patch-clamp recordings
Hippocampal slices for patch clamp recordings were prepared from
C57BL/6N (n = 12), PLX5622-treated mice (n = 9), C57BL6J (n = 10)
and cx3cr1GFP/GFP (n = 9). Whole-cell patch clamp recordings were
performed on CA1 pyramidal neurons at room temperature by using a
Multiclamp 700B amplifier (Molecular Devices, USA). The ACSF (com-
position in mM: NaCl 125, KCl 2, CaCl2 2, MgCl2 1.2, NaH2PO4 1.2,
NaHCO3 25, and glucose 10) was perfused at a rate of approximately
2 ml/min by using a gravity-driven perfusion system. Glass electrodes
(3–4 MΩ) were pulled with a vertical puller (PC-10, Narishige). Pipette
were filled with 135 mM Cs Methanesulfonate, 10 mM Hepes,
0.5 mM EGTA, 2 mM Mg-ATP, 0.3 mM Na3-GTP, and 2 mM MgCl2
(295–300 mOsm, pH 7.2). Cell capacitance was constantly monitored
over the time and experiments where access resistance changed more
than 20% were discarded.
Spontaneous excitatory post-synaptic currents (sEPSCs) were
recorded in ACSF by holding the cell at the reversal potential of GABA
current (70 mV). Miniature excitatory post-synaptic currents (mEPSCs)
were isolated by adding Tetrodotoxin (0.5 mM, TOCRIS) to ACSF in the
perfusion line for at least 10 min before starting acquisition. Signals
were acquired (sampling 10 kHz, low-pass filtered 2 kHz) with DigiData-
1440A using pCLAMP-v10 software (Molecular Devices, USA).
Analysis of sEPSCs and mEPSCs was performed offline using
MiniAnalysis software (Mini Analysis, Synaptosoft Fort Lee, NJ, USA)
with the threshold for detection set at 5 pA. Cumulative probability
curves were constructed by considering 100 consecutive events
each cell.
2.7 | Field excitatory post synaptic potential
recordings
Hippocampal slices for field recordings were prepared from C57BL/6N
(n = 25), PLX5622-treated mice (n = 14), C57BL6J (n = 9) and
cx3cr1GFP/GFP (n = 11).
Slices were transferred to the slice-recording chamber interface
(BSC1, Scientific System Design Inc), maintained at 30–32C and con-
stantly superfused at the rate of 2.5 ml/min with oxygenated ACSF.
At the beginning of each recording, a concentric bipolar stimulating
electrode (SNE-100X 50 mm long Elektronik–Harvard Apparatus
GmbH) was placed in the hippocampus CA1 stratum radiatum for
stimulation of Shaffer collateral pathway projection to CA1. Stimuli
consisted of 100 μs constant current pulses of variable intensities,
applied at 0.05 Hz. A glass micropipette (0.5–1 MΩ) filled with ACSF
was placed in the CA1 region, at 200–600 μm from the stimulating
electrode, in order to measure orthodromically evoked fEPSP. The
paired-pulse ratio (PPR) was measured from responses to two synap-
tic stimuli at 50 ms interstimulus interval. PPR was calculated as the
ratio between the field excitatory post synaptic potential (fEPSP)
amplitude evoked by the second stimulus (A2) and that by the first
(A1; A2/A1). Only the slices that showed stable fEPSP amplitudes
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were included in the experiments. Field EPSP was recorded and fil-
tered (low pass at 1 kHz) with an Axopatch 200A amplifier (Axon
Instruments, CA) and digitized at 10 kHz with an A/D converter
(Digidata 1322A, Axon Instruments). Data acquisition was stored on a
computer using pClamp 9 software and analyzed offline with Clampfit
10 software (both from Axon Instruments).
2.8 | Isolation of CD11b+ cells from adult mice
from brain areas
C57BL6/N mice (ZT4 n = 15, ZT16 n = 13) were taken from cages
and rapidly anesthetized, in no more than 1 min. Animals were
intracardially perfused with PBS, brains were extracted, and the hip-
pocampus, prefrontal cortex, and hypothalamus were isolated and
grinded in Hank's Balanced Salt Solution (ThermoFisher) to obtain
single-cell suspension. Cells were immediately processed for MACS
MicroBeads (Miltenyi) separation. CD11b Microbeads (Miltenyi
Biotec, Cat# 130-049-601; https://www.miltenyibiotec.com/IT-en/
products/cd11b-microbeads-human-and-mouse.html#130-049-601)
were used to magnetically label CD11b+ cells. The cell suspension
was loaded onto a MACS column placed in the magnetic field of a
MACS Separator and the negative fraction was collected. After
removing the magnetic field, CD11b+ cells were eluted as a positive
fraction and the purity was 99% (Garofalo et al., 2017).
2.9 | ATP treatment of microglial primary cultures
from pups
Microglial cells were obtained from mixed glia cultures derived from
the cerebral cortices of post-natal day 0–2 (P0–P2) C57BL6/J mice.
Cortices were chopped and digested in 15 U/ml papain (Sigma, Cat#
P3125) for 20 min at 37C. Cell suspensions were plated
(5  105 cells/cm2) on poly-L-lysine hydrobromide (Sigma, Cat#
P2636) (0.1 mg/ml) coated flasks in growth medium supplemented
with 10% FBS. After 9–11 days, cultures were shaken for 2 h at 37C
to detach and collect microglia cells. These procedures gave almost
pure microglial cell populations as previously described (Lauro
et al., 2010). Cells were seeded on poly-L-lysine coated 12 well plates
(40  104 cells) and 2 days after they were treated with lipopolysac-
charide (LPS, 100 ng/ml) (Sigma Cat# L4391) or ATP (Sigma, Cat#
A6419) (1 mM, 100, 50, and 10 μM) for 4 h.
2.10 | ATP treatment of microglial primary
cultures from adult mice
Sixty-day-old mice were deeply anesthetized and intracardially per-
fused with ice cold PBS. Brains were removed, each hemisphere was
cut into small pieces and disrupted in a glass-teflon homogenizer. Cell
suspension was applied to a 30-μm cell strainer, labeled with CD11b+
Microbeads and passed through MACS Columns (Miltenyi Biotec).
These procedures gave almost pure microglial cell populations as pre-
viously described (Garofalo et al., 2017). Microglia cells were plated in
DMEM/F12 plus GM-CSF (5 ng/ml) on poly-L-lysine coated 24-well
plate (20  104 cells). After 4 days, cells were treated with ATP
100 μM for 4 h.
2.11 | Analysis of cx3cr1 mRNA expression
CD11b+ cells isolated from tissue and cultured microglial cells were
lysed in Trizol reagent (Invitrogen) for isolation of total RNA and puri-
fied by isopropanol precipitation; quality and yield were verified using
the NANODROP One system (Thermo Scientific Scientific).
For RT-qPCR, reverse transcription reaction was performed in a
thermocycler using IScript TM RT Supermix (Biorad) under the follow-
ing conditions: incubation, 25C, 50; reverse transcription, 42C, 450;
inactivation, 85C, 50. RT-qPCR was carried out in a I-Cycler IQ Multi-
color RT-PCR Detection System using SSO Fast Eva Green Supermix
(Biorad). The PCR protocol consisted of 40 cycles at 95C, 3000 and
60C, 3000. For quantification analysis, the comparative Threshold
Cycle (Ct) method was used. The Ct values from each gene were nor-
malized to the Ct value of gapdh in the same cDNA samples. Relative
quantification was performed using the 2ΔΔCt method (Schmittgen
and Livak, 2008) and expressed as fold increase in arbitrary values.
Primer sequences (50–30): gapdh, forward (f): TCGTCCCGT
AGACAAAATGG, reverse (r): TTGAGGTCAATGAAGGGGTC; cx3cr1,
f: TGACTGGCACTTCCTG-CAGA, r: AGGGCGTAGAAGACGGACAG.
2.12 | Immunofluorescence and FACS analysis
For in vitro cell culture studies, primary microglial cells obtained from
C57BL/6N pups (P0-2) were treated with vehicle, LPS (100 ng/ml)
and ATP (100 μM and 1 mM) for 4 h. After incubation, cells were
detached from plates using dispase (1 mg/ml), washed and stained
with anti-CX3CR1 specific monoclonal antibody (PerCP Fluoro-
chrome, Biolegend SA011F11 149009, dilution 1/60). Cells were ana-
lyzed by flow cytometry using a FACSCanto II (BD Biosciences), and
data were elaborated using FlowJo v10.7. The level of CX3CR1
expression (Median Fluorescence Intensity: MFI) was quantified after
subtracting control staining (Fluorescence Minus One: FMO).
2.13 | Statistical analyses
Statistical significance was assessed by Student's t-test, one-way or
two-way ANOVA for parametrical data, as indicated. In particular, for
PCR, statistical analyses were conducted using one-way ANOVA
followed by Dunn's and Tukey post hoc test (Sigmaplot software).
Electrophysiological experiments were analyzed by two-way ANO-
VAs, considering subject (controls, PLX5622 and cx3cr1GFP/GFP mice)
and environmental condition (ZT4 and ZT16) as the between-subject
variables (Sigmaplot software). Post hoc comparisons were performed
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using Holm–Sidak test. For the cumulative distribution analyses, we
applied the Kolmogorov–Smirnov two-sample test (KS) using the
MiniAnalysis software (Synaptosoft Fort Lee, NJ, USA). All mean dif-
ferences were considered statistically significant when p < .05.
For EEG experiments, a statistical analysis of the epochs lasting 8 s
data was performed by Statistica 10.0 packages (StatSoft Inc., www.
statsoft.com). The primary analysis of those epochs was performed on
the sleep duration, whereas the secondary analysis was focused on the
duration of the exploratory movements (the latter was quantitatively
tested in parallel experiments using the DVC cages). Due to the sample
size, non-parametric tests were used. The Wilcoxon test was used for a
within-group analysis of the sleep (NREM + REM sleep) and movement
duration between the light and the dark periods. The Mann–Whitney
U test was used for the between-group analysis.
For the primary analysis of REM and NREM sleep duration, the
p value was corrected (Bonferroni) for 8 statistical comparisons, namely
p < .05/8 = .006= p < .05 corrected. For exploratory purposes, a statis-
tical threshold of p < .05 uncorrected was also used. The statistical com-
parisons were (1) 4 within-group comparison light vs dark for the
C57BL/6, PLX5622, C57BL/6J and cx3cr1GFP/GFP groups; (2) 2
between-group comparisons for the light period for the C57BL/6 versus
PLX5622 groups and the C57BL/6J versus cx3cr1GFP/GFP groups; and
(3) 2 between-group comparisons for the dark period for the C57BL/6
versus PLX5622 groups and C57BL/6J versus cx3cr1GFP/GFP group. Note
that almost all sleep periods were spent in the NREM sleep. The same
design was used for the secondary analysis of movement durations.
Sample size (n/N) refers to the number of: (1) slices/mice, for filed
cell recording analysis; (2) cells/mice for patch clamp recordings;
(3) wells/cultures for in vitro analysis. N refers to the number of mice
for EEG and motor activity analysis. All data are expressed as mean
± standard error of the mean (SEM).
3 | RESULTS
3.1 | Effect of microglial depletion on sleep
duration in the light/dark cycle
To investigate the effect of microglial cell depletion on the wake–
sleep cycle, we treated mice with the CSF-1R inhibitor PLX5622. This
treatment is reported to efficiently and transiently deplete microglia
in several brain regions (Huang et al., 2018), and we confirm this result
in three different brain regions involved in sleep regulation such as
the hypothalamus (the whole structure) (92.81 ± 3.37% depletion),
the prefrontal cortex (PFC) (95.28 ± 2.32% depletion) and the hippo-
campus (93.89 ± 2.76% depletion) (Ono and Yamanaka, 2017; Durán
et al., 2018) (Figure S1). Microglia-depleted mice were analyzed for
video, fronto-parietal EEG and back-muscle EMG recordings in 24 h
and the data analysis was performed for 7 h (from ZT4 to ZT11) in the
light phase and 7 h (from ZT13 to ZT20) in the dark phase. As
expected, both control and PLX5622 treated mice showed longer
sleep (total and NREM sleep) duration during the light phase (Table 1;
Figure 1a,d), and longer movement durations during the dark phase
(Table 1; Figure 1c,f) and REM sleep was shorter in the dark phase for
control mice (Table 1; Figure 1b,d).
Interestingly, when compared to the control, the PLX5622 group
spent a higher amount of time in sleep (total and NREM) during the
dark phase (Table 1, Figure 1a,d). Note that mice spent most of
the sleep duration in the NREM phase (see Figure 1a,d versus b,e).
The latency of the sleep onset was shorter in the PLX5622 group both
in light and dark phases (p < .05 corrected, Table 1). Detailed results
of the analyses within and between groups are reported in Tables S1,
S2, and S3.
Similar results for NREM sleep were obtained when EEG data
were analyzed for longer periods (11 h in the light phase and 11 h in
the dark phase), as shown in Figure S2. All the successive analyses
were performed on shorter periods of 7 h.
To better understand the effects of microglial depletion on sleep,
we performed analyses on circadian variables after PLX5622 treatment
in 12 h light/12 h dark and in 12 h dark/12 h dark cycles. For these ana-
lyses, we took advantage of an innovative system, the digital ventilated
cages (DVC), that automatically records motor activity for prolonged
periods (24 h per day) and with minimal operator intervention, thus
avoiding interfering with animal rhythms. Results shown in Figures S3
and S4 show that no overt variations of circadian variables were
observed between control and PLX5622 treated mice. Figure S3 shows
the comparison of average activity, 24 h activity pattern, acrophase, and
diurnality between the control and PLX5622-treated mice along the
light/dark cycle. To study the effect of microglial depletion on circadian
time (CT), we investigated the effect of PLX5622 treatment in the dark/
dark experimental setting: Figure S4 demonstrates that no significant
variation in the average activity, activity onset, and phase shift were
observed upon PLX5622 treatment in mice housed in 12 h dark 12 h
dark condition, indicating no effects on mouse inner CT.
Analysis of time spent in movement (Figure 1c,f) did not reveal
significant differences among control and microglial-depleted mice,
while total wakefulness phase was decreased both in light and dark
periods (Table 1). Interestingly, comparable results on NREM sleep
duration were obtained using another CSF1R antagonist, PLX3397,
that partially depleted microglial cells (around 88%, data not shown)
(Jin et al. 2017) with an independent set of analyses (Figure S5), con-
firming the role of microglia in modulating NREM sleep duration dur-
ing the dark phase. The REM sleep duration was also not affected by
PLX3397 treatment (Figure S5B, E), while the time in the wake phase
was also decreased (Figure S5C, F). Note that the duration of REM
phase varied in the experimental group shown in Figure 1b and in
Supplementary Figure S5B, from about 1% to 6%, possibly due to
some experimental differences described in Supplementary Materials.
3.2 | Microglial depletion affects hippocampal
synaptic transmission in a daily-phase dependent
manner
In several brain regions, the number and the morphology of dendritic
spines on neurons along with the expression levels of AMPA
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receptors can change across the light/dark cycle, resulting in an
increased frequency and/or amplitude of the mEPSC during the dark
phase (Vyazovskiy et al., 2008; Liu et al., 2010; Maret et al., 2011;
Yang et al., 2014; Bridi et al., 2020). To investigate whether microglia
play a role in the synaptic scaling of miniature events along the light–
dark cycle, we performed patch clamp experiments from CA1 hippo-
campal neurons in control and PLX5622 treated mice, in slices
harvested at ZT4 and ZT16. We found that the phase of the day had
a main effect on the amplitude of mEPSC (F[1,38] = 4.461, p = 0.041)
with higher values during the dark (ZT16: 12.66 ± 0.54 pA, n/N = 10/
4 cells/mice) relative to the light phase (ZT4: 10.82 ± 0.57 pA, n/
N = 16/4, Holm-Sidak post hoc analysis t = 2.332, p = .025)
(Figure 2a, left). Microglia depletion reduced the mEPSCs amplitude
only at ZT16 (t = 2.066, p = 0.045) abolishing the difference observed
at the two times considered (ZT16: 11.16 ± 0.44 pA n/N = 13/4;
ZT4: 10.82 ± 0.48 n/N = 13/5, post hoc t = 0.521, p = 0.605,
Figure 2a, left). Conversely, mEPSC frequency was not different in
control and PLX 5622-treated group (ZT16 CTRL: 0.75 ± 0.13 Hz,
ZT4 CTRL: 0.83 ± 0.13 Hz, t = 0.452, p = 0.654; ZT16 PLX: 0.69
± 0.11 Hz, ZT4 PLX: 0.87 ± 0.11 Hz, t = 1.152, p = 0.745, Figure 2a,
right).
We then measured spontaneous synaptic activity performing the
recordings in the absence of TTX, to better approximate the physio-
logical condition. We found a main effect of phase and treatment on
the sEPSC amplitude (F[1,38] = 6.959, p = .012; F(1,38) = 11.374,
p = .002, respectively (Figure 2b, left). Post hoc analysis showed that
at ZT16 the mean amplitude of sEPSC was higher (ZT16: 14.91
± 1.59 pA, n/N = 10/4 cells; ZT4: 11.68 ± 0.82 pA, n/N = 10/4 cells,
TABLE 1 Time spent by each group in the different behavioral conditions. Mean ± SEM and percentages of the time (h) spent by each mouse
group (i.e., C57BL/6, PLX5622, C57BL/6J, and CX3CR1) in the following behavioral conditions: sleep (non-rapid eye movement + rapid eyes
movement [NREM + REM]), NREM, REM, wakefulness (movement + passive wake), movement, and passive wake durations. The mean values
were calculated considering 7 h of the light phase (of the day) and 7 h of the dark phase, which were considered as representative of 24 h based
on an exploratory analysis carried out at early stage of the study. In those hours, the 8-s epochs classified as “undefined” were very few (i.e., < 1
on 1000), so we did not consider them in reporting the percentages of the time spent in sleep and wakefulness. Asterisks in bold indicate the
statistically significant differences between the experimental (i.e., PLX5622 or CX3CR1) and control (i.e., C57BL/6 or C57BL/6J) mouse groups
(p < .05 uncorrected)
C57BL/6 (N = 10) PLX5622 (N = 9) C57BL/6J (N = 4) CX3CR1 (N = 7)
Mean ± SE (h) Mean ± SE (h) Mean ± SE (h) Mean ± SE (h)
Conditions % ± SE % ± SE % ± SE % ± SE
Sleep duration (NREM + REM) Light 4.0 ± 0.2 4.1 ± 0.2 4.4 ± 0.2 4.4 ± 0.3
57.7% ± 3.0% 58.9% ± 3.2% 62.8% ± 3.1% 62.5% ± 3.9%
Dark 2.2 ± 0.3 3.3 ± 0.1 2.4 ± 0.2 3.1 ± 0.3
31.9% ± 4.2% 47.5% (*) ± 1.7% 34.7% ± 2.5% 44.7% (*) ± 4.3%
NREM duration Light 3.9 ± 0.2 4.0 ± 0.2 4.4 ± 0.2 4.4 ± 0.3
56.4% ± 3.1% 57.2% ± 2.8% 62.4% ± 3.0% 62.2% ± 3.9%
Dark 2.2 ± 0.3 3.2 ± 0.1 2.4 ± 0.2 3.1 ± 03
31.1% ± 4.0% 46.3% (*) ± 1.8% 34.7% ± 2.5% 44.6% (*) ± 4.2%
REM duration Light 0.1 ± 0.0 0.1 ± 0.0 0.03 ± 0.0 0.02 ± 0.0
1.4% ± 0.5% 1.7% ± 0.6% 0.4% ± 0.3% 0.3% ± 0.3%
Dark 0.1 ± 0.0 0.1 ± 0.0 0.003 ± 0.0 0.005 ± 0.0
0.8% ± 0.3% 1.3% ± 0.4% 0.04% ± 0.04% 0.1% ± 0.1%
Wakefulness duration (movement + passive wake) Light 3.0 ± 0.2 2.9 ± 0.2 2.6 ± 0.2 2.6 ± 0.3
42.3% ± 3.0% 41.1% ± 3.2% 37.2% ± 3.1% 37.5% ± 3.9%
Dark 4.8 ± 0.3 3.7 ± 0.1 4.6 ± 0.2 3.9 ± 0.3
68.1% ± 4.2% 52.5% (*) ± 1.7% 65.3% ± 2.5% 55.3% (*) ± 4.3%
Movement duration Light 1.8 ± 0.1 1.6 ± 0.2 2.1 ± 0.3 1.7 ± 0.2
26.0% ± 2.1% 23.5% ± 2.7% 30.0% ± 3.8% 24.9% ± 2.8%
Dark 3.6 ± 0.3 2.8 ± 0.1 2.9 ± 0.2 2.9 ± 0.3
51.0% ± 4.3% 39.8% ± 1.9% 41.1% ± 3.2% 40.9% ± 4.1%
Passive Wake duration Light 1.1 ± 0.2 1.2 ± 0.1 0.5 h ± 0.1 0.9 ± 0.1
16.3% ± 2.2% 17.6% ± 2.0% 7.2% ± 1.3% 12.6% (*) ± 1.9%
Dark 1.2 ± 0.2 0.9 ± 0.1 1.7 ± 0.3 1.0 ± 0.2
17.1% ± 2.5% 12.7% ± 1.3% 24.2% ± 4.9% 14.4% ± 2.6%
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t = 2.855, p = 0.007, Figure 2b, left) and the cumulative probability
curve of sEPSC amplitude was significantly shifted to the right com-
pared to ZT4 group (p < 0.001, KS, Figure 2c, left), indicating an
increased strength of synaptic transmission in the dark phase. Similar
to what observed for mEPSCs, microglia depletion abolished the dif-
ference in the mean sEPSC amplitude between ZT4 and ZT16 (ZT4
PLX5622: 9.98 ± 0.86 pA, n/N = 9/4, t = 0.925; p = .36) (Figure 2b),
resulting in the overlap of the cumulative probability distribution (KS,
p = .28, Figure 2c, left).
In addition, in ZT16 control group, the frequency of sEPSCs was
higher compared to ZT4 (ZT16: 3.702 ± 0.49 Hz, ZT4: 2.2 ± 0.43 Hz,
t= 2.167, p= .037, Figure 2b, right) and the inter-event interval (IEI) cumu-
lative probability curve shifted toward the left (p < .0001, KS, Figure 2c,
right) reflecting an increased sEPSC frequency in the dark. PLX5622
treated mice showed similar sEPSC frequency (ZT16 PLX5622 frequency:
2.26 ± 0.48 Hz; ZT4 PLX5622: 2.55 ± 0.51 Hz, t = .412, p = .683,
Figure 2b, right) and cumulative probability curves at the two zeitgeber
time considered (p = 0.39, KS, Figure 2c, right). We found that both the
amplitude and the frequency of sEPSCs were significantly reduced in the
ZT16 PLX5622 compared to the ZT16 control group (t = 3.310, p = .002;
and t= 2.292, p= .028, respectively). Although at ZT4 no statistical differ-
ence was observed for the mean values of these parameters between
PLX5622 and control group, cumulative distributions for sEPSC amplitudes
were shifted to the left for the treated mice indicating a reduction, albeit
minimal (p < .0001 KS, data not shown). These results indicate that micro-
glial cells have a role in setting the differences in synaptic strength across
the light/dark cycle and their removal reduces these differences (Akiyoshi
et al., 2018).
To further test microglial-dependent differences in basal neuronal
transmission across the light/dark cycle, we measured the paired
pulse ratio (PPR) at 50 ms intervals, a form of short-term plasticity
related to neurotransmitter release probability, by extracellular field
recordings in hippocampal CA1 region. We observed a main effect of
treatment (F[1, 79] = 11.159, p = .001) whereas that of phase was
not significant (p = 0.315). In particular, post hoc analysis revealed
that, at ZT16, microglia depletion increased the PPR value compared
to control (ZT16: PPR = 1.07 ± 0.02, n/N = 31/16; ZT16 PLX5622:
PPR = 1.18 ± 0.04, n/N = 17/7, t = 3.012, p = .004, Figure 2d),
suggesting a reduced probability of glutamate release in the dark
phase. In the light phase, PPR value was not modified by PLX5622
F IGURE 1 Effect of microglial depletion on sleep and movement duration in the dark and light phases. Mean ± SEM and individual
distribution of non-rapid eye movement (NREM) sleep (a), rapid eye movement (REM) sleep (b) and movement (c) duration in 7 h of light versus
7 h of dark in C57BL/6 (control, C. n = 10) and PLX5622-treated (n = 9) mice. The within-group statistical analysis was performed by Wilcoxon
test for paired measures and showed statistical differences for NREM sleep (C ## p = .0025 corrected, z = 2.80, t = 0.00; PLX5622 # p = .0054
corrected, z = 2.54, t = 0.00), REM sleep (C # p = .014 uncorrected, z = 2.19, t = 0.00) and movement duration (C ## p = .0025 corrected,
z = 2.80, t = 0.00; PLX5622 ## p = .0038 corrected, z = 2.66, t = 0.00), in light versus dark conditions. The between-group statistical analysis
was performed by Mann–Whitney U test for unpaired measures and showed increased NREM sleep in PLX5622-treated mice compared to C
(**p = 0.0031 corrected, z = 2.74, U = 11.00), (d–f) time-courses of NREM (d), REM (e) and movement (f) duration at the time-points analyzed.
Data are expressed as a percentage of the total time analyzed and are shown as mean ± SEM
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treatment (ZT4: PPR = 1.12 ± 0.03, n/N = 17/9; ZT4 PLX5622:
PPR = 1.19 ± 0.03, n/N = 16/7, t = 1.81, p = 0.074; Figure 2d).
These results further indicate that microglia, in the dark phase, con-
tribute to the modulation of glutamate release.
We also explored the post-synaptic plasticity processes in the CA1
hippocampal region by recording LTP evoked by two spaced (30 min
apart) Schaffer collateral high-frequency stimulation (HFS) and analyzing
the field excitatory postsynaptic potential (fEPSP) 20 min after each
stimulation. In particular, we recorded LTP during the dark phase, at
ZT16, and the light phase, at ZT4, in control and PLX5622 treated mice.
Following the first stimulation, the main effect of treatment and phase
emerged (F[1, 96] = 5.407, p = .022; F(1, 96) = 6.791, p = .011, respec-
tively). Similarly, after the second stimulation, we found a significant main
effect of phase (F[1, 82] = 9.433, p = .003), whereas those of treatment
were not significant (F[1, 82] = 3.908, p = .052). Post hoc analysis rev-
ealed that after the first train, in control conditions, LTP amplitude did
not show significant differences between ZT4 and ZT16 (ZT4: 1.32
± 0.02 mV, n/N= 26/12; ZT16: 1.29 ± 0.02 mV, n/N= 46/23 p = .316,
F IGURE 2 The depletion of microglia alters synaptic transmission across the light–dark cycle. (a) Top: Representative traces of mEPSCs recorded
at 70 mV from hippocampal CA1 neurons at ZT4 and ZT16 in control (C) and PLX5622 conditions; scale bars: 2 s (horizontal), 10 pA (vertical).
bottom: histograms of the mean amplitude (left) and frequency (right) for mEPSCs at ZT4 and ZT16 in C and in PLX5622 conditions. Miniature EPSC
amplitude is increased in C during dark condition (ZT16: 10/4 cells/mice; ZT4: 16/4, t = 2.332, p = .025) and PLX5622 treatment reduces mEPSC
amplitude at ZT16 (ZT16 PLX5622: 13/4 cells/mice, t = 2.066, p = .045) compared to C, abolishing the difference at the two times considered (ZT4
PLX5622: 13/5, post hoc 13/4, t = 0.521, p = .605). Frequencies of mEPSC were similar in all groups. (b) Top: representative traces of sEPSC at ZT4
and ZT16 in control (C) and PLX5622 conditions; bottom: histogram of the mean amplitude (left) and frequency (right) for sEPSCs in control
conditions (C) and after PLX5622 treatment. Spontaneous EPSC amplitude is increased in C during dark condition (ZT16: 10/4 cells/mice; ZT4: 10/4,
t = 2.855, p = .007) and reduced upon PLX5622 treatment compared to control (ZT16 PLX5622: 10/4 cells/mice, t = 3.310, p = .002). The
frequency of sEPSC is increased in C at ZT16 (t = 2.167, p = .037) but reduced after PLX5622 treatment only at dark (t = 2.292, p = .028). (c) Left.
The cumulative probability curve for sEPSC amplitude is shifted rightward at ZT16 (n = 1200 events) compared to ZT4 (n = 900 events) in C (KS,
p < .001), reflecting increased sEPSC amplitude. Right. The cumulative function for the inter-event intervals (right) is shifted to the left in control (C) at
ZT16 (KS, p < .0001), in line with the increased sEPSC frequency. Upon PLX5622 treatment the cumulative functions for both sEPSC amplitude and
IEI were similar at the two time points (KS, p = .28 and p = .39). (d) Representative fEPSP traces (left) and mean values (right) for PPR experiments
performed (ISI = 50 ms) at ZT4 and ZT16 in control (17/9 and 31/16 slices/mice) and PLX5622 treated mice (16/7 and 17/7 slices/mice respectively.
PPR is increased in PLX5622-treated mice at ZT16 (t = 3.012, p = .004). Scale bars: 0.3 mV (vertical), 10 ms (horizontal). Data are shown as mean
± SEM. Statistical analysis was performed with Two-way ANOVAs, Holm-Sidak post hoc comparison. *, # p < .05, **, ## p < .01. Cumulative
probability functions were compared with Kolmogorov–Smirnov test
CORSI ET AL. 9
Figure S6A, B), indicating that hippocampal LTP is not affected by the
light/dark cycle. By contrast, in microglia-depleted mice, LTP amplitude
was higher at ZT4 compared to ZT16 (ZT4: 1.46 ± 0.06 mV, n/N = 12/
7; ZT16: 1.34 ± 0.04 mV, n/N = 14/8; p = .016, Figure S6A, B), being at
ZT16 similar and at ZT4 enhanced compared to control (p = .551 and
p= .012, respectively). Similarly, after the second stimulation, LTP ampli-
tude in control group did not show significant difference between the
two phases (ZT4:1.50 ± 0.04 mV, n/N = 22/11; ZT16: 1.43 ± 0.04 mV,
n/N = 38/21, p = .229, Figure S6A,B), whereas microglial depletion cau-
sed an increase of LTP amplitude at ZT4 compared to ZT16 (ZT4: 1.68
± 0.09 mV, n/N = 11/7; ZT16: 1.42 ± 0.064 mV, n/N = 13/8, p = .005,
Figure S6A,B). Moreover, at ZT4, the LTP amplitude of PLX5622 treated
mice resulted increased respect to control (p= .016).
These results suggest that in basal condition LTP amplitude do
not differ between ZT4 and ZT16. By contrast, microglia depletion
uncovers an inhibitory role of microglia during the light phase, being
the LTP level increased by PLX5622 treatment.
3.3 | Microglial cx3cr1 expression decreases during
the light period
Pieces of evidence describe the role of the CX3CL1/CX3CR1 pair in
modulating neuron to microglia communication (reviewed in Limatola
and Ransohoff, 2014; Trettel et al., 2020), as well as in regulating syn-
apse morphology and functioning (Zhan et al., 2014; Paolicelli
F IGURE 3 Microglial expression of cx3cr1 decreases during the light phase and upon ATP stimulation in vitro. (a) cx3cr1 mRNA expression
analysis by RT-PCR in CD11b + cells obtained at ZT4 and ZT16 from hippocampus (n = 12 and 13 mice respectively), PFC (n = 9 and 12 mice
respectively) and hypothalamus (n = 15 and 13 mice respectively) and individual distribution of data. Data are expressed as cx3cr1 mRNA fold
increase normalized to gapdh expression; values shown are normalized to ZT16. cx3cr1 mRNA levels are increased during dark in all regions
analyzed. Data are expressed as mean ± SEM. * p = .034 (hippocampus) and p = .03 (PFC); ** p < .001 (one-way ANOVA). (b) cx3cr1 mRNA
expression analysis by RT-PCR in primary wild type microglia obtained from pups treated for 4 h with LPS (100 ng/ml) and ATP at different
concentrations. LPS treatment and ATP at 1 and 100 μM decrease cx3cr1 mRNA levels. Data are expressed as cx3cr1 mRNA fold increase
normalized to gapdh expression; values shown are normalized to vehicle (c). Data are expressed as the mean ± SEM. ** p < .001 (one-way
ANOVA, followed by Dunn's post hoc test). (c) Median fluorescence intensity (MFI) of CX3CR1 staining is decreased in primary wild type
microglia stimulated for 4 h with LPS (100 ng/ml) and ATP 1 mM and 100 μM. Data are expressed as mean ± SEM of the MFI. ** p < .001 C
versus LPS, * p = 0.006 C versus ATP 1 mM, one-way ANOVA followed by Holm-Sidak post hoc test. (d) cx3cr1 mRNA expression by RT-PCR is
also decreased in primary wild type microglia obtained from adult mice following 4 h of ATP (100 μM) treatment. Data are expressed as mean
± SEM of cx3cr1 mRNA fold increase normalized to gapdh expression; values shown are normalized to vehicle (c). ** p < 0.001 (Student's t-test)
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et al., 2014). We investigated whether the diurnal cycle affected
microglial expression of CX3CR1, which is involved in communication
with neuronal cells. With this aim, we performed RT-qPCR analysis on
enriched microglial population (CD11b+ cells) isolated from the brain
of mice at ZT4 and ZT16, to analyze cx3cr1 expression. Data shown in
Figure 3a indicate that three brain regions analyzed, cx3cr1 expression
was significantly reduced during the light period (hippocampus: ZT16:
1 ± 0.07, N = 13; ZT4: 0.72 ± 0.12, N = 12, p = .034; PFC: ZT16: 1
± 0.12 N = 12; ZT4 0.74 ± 0.11, N = 9, p = .03; hypothalamus: ZT16:
1 ± 0.08, N = 13; ZT4: 0.42 ± 0.08, N = 15, p < .001 One-way
ANOVA), suggesting a phase-dependent modulation of neurons-
microglia communication through this signaling pathway.
Since it has been reported that brain levels of ATP increase during
the sleep phase (Dworak et al., 2010), we stimulated primary micro-
glial cultures with different concentrations of ATP to investigate the
mechanisms involved in the light-dependent modulation of cx3cr1
expression. Results presented in Figure 3b show that extracellular
ATP reduces cx3cr1 expression in primary microglia obtained from
pups in a concentration-dependent way. LPS was used as positive
control for cx3cr1 modulation (as reported by Boddeke et al., 1999;
Wynne et al., 2010) (C: 1 ± 0.10, n/N = 6/3 vs. LPS: 100 ng/ml 0.14
± 0.03, n/N = 16/3, p < .001; ATP 1 mM: 0.19 ± 0.05, n/N = 8/3,
p < .001; ATP 100 μM: 0.43 ± 0.10, n/N = 9/3, p = .01; ATP 50 μM:
0.58 ± 0.14, n/N = 8/3, p = .17; ATP 10 μM: 0.85 ± 0.19; n/N = 8/3,
p = .99; one-way ANOVA followed by Dunn's post hoc test). We also
investigated CX3CR1 receptor expression upon extracellular ATP
stimulation in cultured microglial cells by FACS analysis. Figure 3c
shows that ATP reduces the expression of CX3CR1, confirming the
reduction of cx3cr1 mRNA expression (C: 7822 ± 171 vs. ATP 1 mM:
7029 ± 83, p = .006; ATP 100 μM: 8043 ± 144; n/N = 3/3 per condi-
tion; p = .27, one-way ANOVA followed by Holm-Sidak post hoc
test). LPS was again used as positive control (LPS 100 ng/ml: 5745
± 122, n = 3/3; C vs. LPS, p < .001). Moreover, we confirmed the
reduction of cx3cr1 expression due to ATP stimulation on microglial
cells obtained from adult mice, as shown in Figure 3d (C: 1 ± 0.1; ATP
100 μM: 0.28 ± 0.07; n/N = 3/3; p < .001, Student's t-test). These
results led us to speculate that the increased levels of ATP present in
the brain in the first hours of sleep, due to reduced use of energy dur-
ing the NREM phase (Dworak et al., 2010), could reduce cx3cr1
expression in microglia, thus affecting their response to neuronal
CX3CL1 signaling.
3.4 | CX3CR1-CX3CL1 signaling underlies
microglia effects along the light/dark cycle
To investigate the role played by CX3CR1 signaling in mediating
microglial effects on the light/dark cycle, we extended our study to
the cx3cr1GFP/GFP mice. For these experiments, C57BL/6J mice were
used as control, due to the similarity in the genetic background.
We first investigated sleep duration in the light/dark cycle. As for
the PLX5622 treated mice, the cx3cr1GFP/GFP mice showed longer
NREM sleep durations during the dark phase (44.6 ± 3.2%) in
comparison with the control group (34.7% ± 2.49%) (Figure 4a
p = .04 uncorrected, and Table 1 and Tables S1–S3). Similar results
were obtained also considering the total sleep (NREM + REM;
p = .035 uncorrected). For the REM sleep, control mice showed sig-
nificant difference between the light and dark (p = .04 uncorrected),
whereas no differences in REM sleep were observed for cx3cr1GFP/GFP
(p = .27) (Figure 4b). No significant differences were observed in the
amount of time in movement during the dark phase in cx3cr1GFP/GFP
mice (40.91% ± 3.12%) in comparison with the control group
(41.08% ± 3.17%) (Figure 4c p = .5).
Overall, these data confirm a relevant role of microglia in sleep
duration along the daily cycle, highlighting the involvement of
CX3CR1 signaling pathway. We then recorded synaptic transmission
in mice lacking cx3cr1. When analyzing sEPSC amplitude, we did not
find a main effect of genotype and phase, but a statistically significant
interaction between the two factors emerged (p = .021). In particular,
Holm-Sidak post hoc analysis revealed that in control mice the mean
sEPSC amplitude was higher in the dark (ZT16: 15.68 ± 0.96 pA n/
N = 12/3, ZT4: 13.21 ± 0.86 pA, n/N = 15/3, t = 2.084, p = .043,
Figure 4d, left) with a rightward shift of the cumulative distribution
compared to light condition (KS test p < .0001, Figure 4e, top left).
Interestingly, in cx3cr1GFP/GFP mice sEPSC amplitude was similar at
ZT4 and ZT16 (ZT4: 14.86 ± 0.96 pA, n/N = 12/3; ZT16: 12.901
± 0.92 pA, n/N = 13/3 cells, t = 1.468, p = 0.149 Figure 4d, right)
with only a minor leftward shift of the cumulative distribution func-
tion during light condition (KS p = 0.003 Figure 4e, bottom left), reca-
pitulating what observed in PLX5622-treated mice. In addition, at
ZT16 cx3cr1GFP/GFP mice showed a significant reduction of sEPSC
amplitude compared to control mice (t = 2.084, p = .042) as observed
in microglia depleted mice (see Figure 2) Figure 4d, left). In C57BL/6J,
we did not observe a difference in the mean sEPSC frequency at light
(ZT4:1.76 ± 0.32 Hz) compared to the dark (ZT16: 2.08 ± 0.34 Hz,
t = 0.675, p = .503, Figure 4d, right); however, the cumulative distri-
bution curve for IEI was significantly shifted toward the left at ZT16
(KS p = .0036, Figure 4e, top right). In cx3cr1GFP/GFP mice, we found
no difference either for the mean values at ZT4 (2.05 ± 0.36 Hz) and
ZT16 (2.05 ± 0.34 Hz, t = 0.000727, p = .99, Figure 4d, right) and the
cumulative functions for IEI (KS p = .748) (Figure 4e, bottom right).
When we measured short-term plasticity, a significant interaction
between genotypes and phases emerged (p = .008) and post hoc anal-
ysis revealed that in the dark PPR was higher in cx3cr1GFP/GFP com-
pared to control (ZT16 cx3cr1GFP/GFP: 1.14 ± 0.02, n/N = 15/6; ZT16
CTRL: 1.07 ± 0.03, n/N = 13/5, t = 2.144, p = .038, Figure 4f,g),
whereas in the light phase it was similar, as observed in microglia-
depleted mice (ZT4 cx3cr1GFP/GFP: 1.11 ± 0.02, n/N = 12/5; ZT4
CTRL: 1.19 ± 0.04, n/N = 8/4, t = 1.803, p = .078) (see Figure. 2d).
Of note, at difference with C57BL/6N, in C57BL/6J control mice the
PPR at ZT4 was increased respect to ZT16 (ZT16: 1.07 ± 0.03, n/
N = 13/5; ZT4: 1.19 ± 0.03, n/N = 8/4, t = 2.924, p = .005), indicat-
ing PPR differences in the two mouse strains.
In addition, we investigated long-term plasticity also in cx3cr1GFP/GFP.
LTP amplitude of the transgenic mice at ZT4 and ZT16 did not show sig-
nificant differences (ZT4: 1.41 ± 0.03 mV, n/N = 25/10; ZT16: 1.39
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F IGURE 4 c3cr1 deficiency effects on sEPSC and video-EEG recordings. Mean ± SEM and individual distribution of non-rapid eye movement
(NREM) sleep (a), non-rapid eye movement (REM) (b) sleep and movement (c) duration in 7 h of light versus 7 h of dark in cx3cr1GFP/GFP mice
(n = 7) and control mice (C; n = 4). The within-group statistical analysis was performed by Wilcoxon test for paired measures and showed
statistical differences for NREM sleep (C # p = .03 uncorrected, z = 1.83, t = 0.00; cx3cr1GFP/GFP ## p = .0089 uncorrected, z = 2.36, t = .00),
REM sleep (C # p = .04 uncorrected, z = 1.10, t = 2.00) and movement duration (cx3cr1GFP/GFP ## p = 0.0089 uncorrected, z = 2.36,
t = 0.00), in light versus dark conditions. The between-group statistical analysis was performed by Mann–Whitney test for unpaired measures
and showed increased NREM sleep (* p = 0.04 uncorrected, z = 1.80, U = 4.00) in cx3cr1GFP/GFP mice respect to (c,d) representative traces of
spontaneous EPSC (top) and histograms for the mean amplitude and frequency (bottom) in controls (C) and cx3cr1GFP/GFP mice at ZT4 and ZT16.
The amplitude of sEPSC is increased in C during dark (ZT16 C: 12/3 cells/mice, ZT4 C: 15/3, t = 2.084, p = 0.043) and reduced in cx3cr1GFP/GFP
mice in dark (13/3, t = 2.084, p = .042). Scale bars: 1 s (horizontal), 20 pA (vertical). (e) Cumulative probability function for sEPSCs amplitudes
compared at the two daily times in controls (ZT4:1121 and ZT16:1267 events) showed a rightward shift at ZT16 (KS, p < .0001, top left). The IEI
cumulative function is shifted to the left in C at ZT16 indicating an increased sEPSC frequency (KS, p = .0036, top right). No shift is detected in
cx3cr1GFP/GFP mice for sEPSC amplitude and IEI at the two time points considered (KS, p = .748 and p = .503, bottom). (f) Representative fEPSP
traces for PPR experiments performed (ISI = 50 ms) at ZT4 and ZT16 in controls and cx3cr1GFP/GFP. (g) Histogram of the mean values of PPR at
ZT4 and ZT16 in control (C, ZT4: 8/4 and ZT16: 13/5 slices/mice) and cx3cr1GFP/GFP mice (ZT4: 8/4 and ZT16: 15/6 slices/mice). Paired-pulse
ratio values are decreased in control (t = 2.924, p = .005) and increased in cx3cr1GFP/GFP mice (t = 2.144, p = .038) at ZT16. Scale bars: 0.3 mV
(vertical), 10 ms (horizontal). Data are shown as mean ± SEM statistical analysis was performed with two-way ANOVAs, holm-Sidak post hoc
comparison. *, # p < .05, **, ## p < .01. Cumulative probability functions were compared with Kolmogorov–Smirnov test
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± 0.04 mV, n/N = 22/10; p = 0.558, Figure S6C, D). However, at ZT4,
LTP amplitude of cx3cr1GFP/GFP mice was significantly increased com-
pared to control (p = .037) similarly to what observed in PLX5622
treated mice (see Figure S6A, B). Comparably, after the second stimula-
tion, LTP amplitude analyzed in control and cx3cr1GFP/GFP mice did not
show significant difference between the two phases (for control: ZT4:
1.41 ± 0.07 mV, n/N = 9/6; ZT16: 1.51 ± 0.06 mV, n/N = 15/9;
p = .333; for cx3cr1GFP/GFP: ZT4: 1.61 ± 0.05 mV, n/N = 19/9; ZT16:
1.53 ± 0.05 mV, n/N = 18/8; p = 0.253, Figure S6C, D). However, at
ZT4, LTP amplitude of cx3cr1GFP/GFP mice was significantly increased com-
pared to control (p = .03), resembling what was observed in microglial-
depleted mice.
Altogether, these data indicate that cx3cr1 participates in regulat-
ing the phase-dependent microglial alterations.
4 | DISCUSSION
In this study, we investigated the role of microglia in the changes
associated to sleep/wake phases throughout the 12:12 light/dark
cycle, focusing on the modulation of hippocampal synaptic functions
and on behavioral states upon microglial depletion with CSF-1R inhib-
itor. We demonstrate for the first time that the microglial depletion
with PLX5622 increases the time spent by mice in the NREM sleep
during the dark phase. Upon microglia depletion, we also reported a
reduction in the hippocampal excitatory neurotransmission in the dark
and an increased long-term potentiation during the light phase indi-
cating that microglia cells play a role in shaping neuronal functions
along the daily cycle.
In line with previous data reporting post-synaptic changes occur-
ring during wakefulness, such as increased levels of hippocampal
AMPA receptor subunits and ultra structural spine modifications
(Vyazovskiy et al., 2008 Liu et al., 2010; Yang et al., 2014; de Vivo
et al., 2017), we found an increased amplitude of both miniature and
sEPSC events recorded in the CA1 hippocampal region of mice at
ZT16. In addition, at ZT16, we measured an increase in sEPSC fre-
quency and a parallel reduction in the PPR, indicating that also presyn-
aptic changes occur along the daily cycle that can be ascribed to
modification of the probability of glutamate release (Zucker, 1989).
Overall, our data support the idea of a net synaptic potentiation taking
place during wakefulness in the hippocampus, in accordance with the
synaptic homeostasis hypothesis (SHY) that proposes sleep as a
period necessary to maintain a proper control of synaptic strength in
the brain (Tononi and Cirelli, 2003).
Our data that microglial depletion with PLX5622 reduced the
amplitude of both mEPSC and sEPSC at ZT16, abolishing the phase-
dependent differences in basal synaptic transmission, suggest that
microglial cells predominantly control the synaptic strength during the
wake phase. Previous studies demonstrated that the direct contact
between microglial processes and synapses in awake mice reflects
enhanced synaptic activity and that partial microglial ablation
decreased the synchronization of evoked neural activity (Akiyoshi
et al., 2018). In accordance with our findings, microglial depletion in
rats has been associated with decreased total hippocampal synaptic
transmission and impaired cognitive function (Yegla et al., 2021). On
the other hand, it has been also reported that chronic microglial deple-
tion increases both excitatory and inhibitory synaptic connections to
excitatory cortical neurons (Liu et al., 2021). This evidence, together,
concurs to highlight a prominent role of microglia in sculpting neuro-
nal circuit connectivity and regulating subsequent functional activity
in a region-specific manner.
Microglial depletion with PLX5622 is an efficient and reversible
event (Elmore et al., 2014; Dagher et al., 2015) but recent evidence
showing that, in addition to depleting microglia, PLX5622 also induces
long-term changes in the peripheral myeloid and lymphoid cells must
be considered (Lei et al., 2020). Furthermore, it has been shown that
not the entire population of microglia responds to CSF-1R antagonists
and a small percentage persists with depletion, which could be
responsible for some of the observed effects (Elmore et al., 2014).The
fractalkine receptor CX3CR1 has a key role in mediating the commu-
nication among neurons and microglial cells, in physiological and path-
ological conditions (Maggi et al., 2011; Limatola and Ransohoff, 2014).
We report that, similarly to what observed upon microglial depletion,
cx3cr1GFP/GFP mice had no phase-dependent differences in sEPSC
amplitude, indicating that the fractalkine/CX3CR1 signaling between
neurons and microglia is necessary for the wake-dependent increase
of excitatory synaptic transmission. Similarly, we observed a reduction
in the frequency of sEPSC and a corresponding increase of the PPR at
ZT16 both in microglial-depleted and in cx3cr1GFP/GFP mice,
suggesting that, during wake, microglia positively modulate presynap-
tic glutamate release probably trough the CX3CR1 signaling.
Several evidence demonstrated that sleep is relevant for initial
memory encoding and subsequent long-term memory consolidation,
exerting effects on molecular, cellular and network mechanisms of
plasticity (Abel et al., 2013, Klinzing et al. 2019). Hippocampal synap-
tic plasticity may vary with the time of day: diurnal variations in the
incidence and magnitude of LTP in the CA1 region have been
reported, with the largest responses occurring in the day (Harris and
Teyler, 1983; Raghavan et al., 1999) or in the night (Chaudhury
et al. 2005, Jilg et al., 2019; Dana and Martinez Jr, 1984; Leung
et al., 2003). The variability of these results can be related to the dif-
ferent experimental conditions, such as stimulation protocol and ani-
mal model used, but also to the strong dependence of plasticity to the
phase of sleep (NREM vs. REM) which are difficult to assess in ex vivo
preparations. For these reasons, our results on the alterations of hip-
pocampal LTP upon microglial alterations in the dark and light phase
must be interpreted considering these experimental limitations. In
control conditions, we report no differences in LTP magnitude at ZT4
and ZT16. However, both microglial depletion and CX3CR1 deletion,
induce an increase of LTP amplitude at ZT4, as previously reported
(Maggi et al., 2011). It can be speculated that interfering with
microglia during this period affects the production of cytokines such
as interleukin-1 and tumor necrosis factor-α which have been associ-
ated to NREM induction (Hide et al., 2000; Shieh et al., 2014) and LTP
inhibition (Prieto et al., 2019). Although further experiments are nec-
essary to finely define microglial function on long term synaptic
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plasticity along the circadian cycle, our data demonstrate that
microglia differentially affect LTP and synaptic strength in the light/
dark phases.
Previous data demonstrated that hampering microglial activities
with minocycline in aged rats (Griffin et al., 2006) or impairing
fractalkine signaling in the cx3cr1 knockout mice (Maggi et al., 2011;
Milior et al., 2016) potentiated the hippocampal synaptic plasticity.
Together, these data indicate that the phase-dependent microglial
effects on hippocampal neurotransmission are mediated via the
expression of cx3cr1.
Microglial depletion with PLX5622 or cx3cr1 deletion results in
alteration of NREM phase duration and reduced excitatory neuro-
transmission in the dark, likely reflecting a key role for cx3cr1
expressing microglial cells for the homeostasis of these functions. Dif-
ferent results on sleep duration have been previously reported when
microglial activity is acutely perturbed with the drug minocycline, also
in conditions of sleep deprivation (Wisor et al., 2011). These mixed
findings may be explained by alternative off-target effects of min-
ocycline, or by distinct functional states of microglia in the different
experimental conditions.
We observe that the depletion of microglia did not affect REM
sleep. Even if we cannot provide experimental explanations for this
specific effect of microglial cell depletion, we could speculate that
microglial cells mostly impact on circuits involved in wake during the
active phase, such as the hypothalamic orexin and MHC neurons (Lee
et al., 2005; Hassani et al., 2009). Further experiments are needed to
better understand these differences.
We hypothesize that the reduction of cx3cr1 expression in micro-
glial cells isolated from three different brain regions of mice at ZT4
could be explained by a direct effect of ATP accumulated in the brain
during sleep (Dworak et al., 2010; Krueger et al., 2010; Marpegan
et al., 2011). This hypothesis is supported by data showing that,
in vitro, ATP administration decreases cx3cr1 expression in microglia.
The accumulation of ATP during sleep has been associated with the
need to replenish the brain energy sources (Burkeen et al., 2011). ATP
is also released during neuronal activity and it is a recognized danger
signal for brain parenchyma (Rodrigues et al., 2015). Extracellular ATP
can reach high local concentrations, especially at regions of cell-to-cell
contact (Pankratov et al., 2006), but it must be considered that ATP is
rapidly degraded with the production of adenosine, which is a very
well described sleep regulator (Porkka-Heiskanen et al., 1997;
Stenberg et al., 2003). A recent report describes an ATP-dependent
regulation of adenosine-mediated microglial depression of neuronal
firing (Badimon et al., 2020). We hypothesize that the ATP-induced
reduction of cx3cr1 expression during the light phase represents the
activation of coordinated communication mechanisms among
astrocytes-microglia and neuronal cells to re-tune synaptic activities
and the strength of circuitry in the different day phases to allow for
learning, memory and environmental adaptation.
We show that PLX5622 treatment had minor effects on motor
activity and only during the light phase. Previous studies reported that
microglial depletion did not alter behavior, locomotor, or cognitive
activity in mice, but improved cognition in the 3xTg-AD mouse model
of Alzheimer's disease and in model of cranial irradiation (Elmore
et al., 2014; Dagher et al., 2015; Acharya et al., 2016). Other studies
report that altered cerebellar CSF-1R signaling affects motor learning
and social interaction (Kana et al., 2019). The different outcomes on
motor functions could be explained by the different experimental con-
ditions and by the long- versus short-term analysis performed to
detect alterations of basal motor activities.
In this study, we did not observe specific effects of microglial
depletion on circadian internal rhythms, as demonstrated by the
absence of alteration of specific behavioral parameters such as the
mean activity, the activity onset, and the phase shift in a dark/dark
housing condition. This led us to speculate that the effects of micro-
glial depletion on total sleep and NREM sleep duration are due to
modulation of homeostatic processes involved in the control of the
sleep/wake phase rather that circadian mechanisms.
To conclude, several studies investigating the role of microglial
cells in the sleep/wake cycle focused on the effects induced by condi-
tions of sleep deprivation, with different experimental approaches,
from gentle handling to forced stimulation of laboratory animals
(Bellesi et al., 2017; Wadhwa et al., 2017; Tuan and Lee 2019; Hall
et al., 2020). Keeping animals awake involves the activation of the
hypothalamic–pituitary–adrenal axis, thus contributing to different
levels of stress; this must be considered as additional variable
together with sleep loss to decipher the observed effects (Meerlo
et al., 2002; Havekes and Aton, 2020). In this study, we demonstrate
that microglia participate in the regulation of sleep/wake cycle and
synaptic transmission in a phase-dependent manner. Previous studies
reported microglial alteration upon chronic sleep deprivation proto-
cols (Bellesi et al., 2017), hypothesizing that prolonged sleep loss,
priming microglial cells, could increase the brain susceptibility induced
by a secondary insult. The variations in cx3cr1 expression across dif-
ferent zeitgeber times suggest that the functional interactions of
microglia with hippocampal synapses vary along the light/dark cycle.
The observation that the lack of cx3cr1 parallels the depletion of
microglia on sleep and synaptic transmission strongly indicates that
the CX3CR1/CX3CL1 signaling pathway is crucial for the homeostatic
role of microglia in the sleep/wake cycle. Our data led us to speculate
that microglial cells, through CX3CR1 signaling, participate in res-
haping the glutamatergic synaptic transmission with pre- and postsyn-
aptic mechanisms, contributing to the synaptic up scaling taking place
during wake. Further investigations will be necessary to understand
how CX3CR1 mediates these effects.
Additional studies targeting the sleep pressure and the circadian
processes will be also necessary to clarify the detailed neurophysio-
logical mechanisms underlying these effects.
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